Collingwood has announced the re-signings of young duo Will Hayes and Roan Steele to new deals. Hayes, who was already contracted for next year, penned a two-year extension, taking him until the end ...
Every so often, the security program needs a revamp. Success hinges on establishing clear priorities, avoiding common mistakes, and keeping the personal toll in check. In 2024, Marriott received a ...
Successful business people giving each other a high five in a meeting. Two young business professionals celebrating teamwork in an office. Organizations often face the challenge of creating a truly ...
NEW JERSEY (PIX11) – Are you waiting for a check from New Jersey’s ANCHOR program? The program is giving tax relief to some homeowners and renters who lived in the state in 2024. The state’s Division ...
Homeowners with battery storage systems can now monetize their investment through the Duke Energy Power Manager program, which offers substantial monthly bill credits in exchange for limited grid ...
If you buy something through a link in this article, we may earn commission. Pricing and availability are subject to change. You can watch coverage of this week's LSU vs. Ole Miss game starting at ...
DUBAI, United Arab Emirates — Iran weighed Sunday how to respond to reimposed United Nations sanctions over its atomic program, with one lawmaker suggesting parliament would consider potentially ...
MSD and Eisai presented the data at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The ...
The Trump administration is expected to dramatically cut funding for a permanent housing program — a move that could potentially reexpose tens of thousands of people to homelessness. More than half of ...
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: Image Credit: Ian ...
Merck & Co (MSD) has taken the first of two possible plunges in its ongoing collaboration with Evaxion, gaining the rights to a mystery infectious disease vaccine candidate. The US big pharma decided ...